HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of recurrent esophageal cancer with tracheal invasion treated by chemo-radiotherapy (CRT) after placement of tracheal stent that maintained complete response (CR) for two years].

Abstract
Frequently advanced or recurrent esophageal cancer was invasive trachea and often causing hemoptysis, stenosis and dyspnea. Occasionally, these cases were treated by a placement of tracheal stent. The placement effect was quickly and a main symptom of dyspnea was improved dramatically. However, the most of the cases were in poor prognosis with advanced cancer treated by chemo-radiotherapy (CRT). We experienced a case of recurrent esophageal cancer with tracheal invasion treated by placement of tracheal expandable metallic stent (EMS). A case was a 73-year-old man (at first admission). He was performed esophagectomy with tracheotomy against esophageal carcinoma at cervical portion. Eighteen month later, a local recurrence with tracheal invasion was appeared. The tracheal covered stent was inserted at the recurrent site. After stenting, CRT was performed with 5-FU and docetaxel. The effect of CRT was complete response (CR). Hence, a stent was removed from trachea. No recurrence was observed at the site and maintained a CR condition for two years after CRT.
AuthorsKatsunori Ami, Takeshi Nagahama, Masayuki Ando, Yoshihisa Watayou, Hidetoshi Amagasa, Hideaki Ganno, Kenichirou Hataji, Yoshihito Kawasaki, Toshiaki Kurokawa, Akira Fukuda, Shikofumi Tei, Kuniyoshi Arai
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 12 Pg. 2331-3 (Nov 2010) ISSN: 0385-0684 [Print] Japan
PMID21224563 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Taxoids
  • Docetaxel
  • Fluorouracil
Topics
  • Aged
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Combined Modality Therapy
  • Docetaxel
  • Esophageal Neoplasms (pathology, therapy)
  • Fluorouracil (administration & dosage)
  • Humans
  • Male
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Recurrence, Local
  • Remission Induction
  • Stents
  • Taxoids (administration & dosage)
  • Trachea (pathology)
  • Tracheal Neoplasms (pathology, therapy)
  • Tracheal Stenosis (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: